''“……我们还需要更大型的试验确定合适的抗血栓药物组合”(PCI) who also have an indication for long-term anticoagulation,. T
‘hard’ clinical endpoints, and increased rates of adverse effects, when niacin is added to statinthe
AF)burden has been assessed in a small, single-centre, proof-of-.“”.The study involved a 3-month co
However,, such as the heart and vasculature, is largely unknown. Xiao et al.(>1,000 mg per day)(CV
more with better resultsChung-, neoadjuvant treatment and living-donor liver transplantation. Patie
free therapy for hepatitis C?,. Within the next 3 years,.. In light of this changing land?scape,..?
INTERVENTIONAL CARDIOLOGY IN 2012—We are ‘shocked’, ‘frozen’,and ‘freed’ by new data In 2012,...
HEART FAILURE IN 2012--Trial data resolve gaps inevidence-,(HF).1 The most--receptorantagonist epler
Key Advances:■(dalcetrapib)■,,■ HDL particle number,assessed by NMR,,,,..1Furthermore,.2On the basis
é., including stroke prevention, recanalization and thrombolysis, neuroprotection,.,.— primary preve
Studies have shown that β-blockers andn-3-,,.Medicine is evolving rapidly, and cardiology is no ex
particularlyin younger patients— acutemyeloid leukaemia (AML). In 2012,(ALFA). In this randomized p
Theincidence of gastro-.;;.In 2012, the final results of the CROSS study,-..–3 N0–1 staged cancers;